Tuberculosis Screening Requirements for Childcare Workers
Tuberculosis screening is a standard pre-employment and ongoing health requirement for childcare workers across the United States — one that sits at the intersection of public health law, state licensing codes, and the practical realities of caring for young children who cannot yet advocate for their own health. The rules vary considerably by state, the type of screening accepted has evolved as medical guidance has shifted, and the consequences of a missed case in a group care setting can ripple far beyond a single classroom. This page covers how screening requirements are structured, what tests are used, and where the decision points typically fall.
Definition and scope
Tuberculosis (TB) screening in the childcare context means the formal assessment — through a recognized diagnostic method — of whether a childcare worker has been infected with Mycobacterium tuberculosis, the bacterium that causes TB. The goal is not to detect active disease in symptomatic workers (that would typically be caught through other medical channels) but to identify latent TB infection (LTBI), which has no outward symptoms and yet can progress to active, transmissible disease.
The scope of who is covered tends to follow licensing. Under most childcare licensing requirements by state, TB screening applies to any person who works in a licensed facility and has direct, unsupervised contact with children — this typically includes lead teachers, assistant teachers, family childcare home providers, and aides. Volunteers with regular contact are often included. Administrative staff who do not enter child-occupied spaces are frequently excluded, though some states apply blanket requirements regardless of role.
The Centers for Disease Control and Prevention (CDC) classifies childcare workers as a priority population for TB screening, given the congregate nature of childcare settings and the presence of immunologically immature children. The Occupational Safety and Health Administration (OSHA) does not maintain a TB-specific standard for childcare, but the agency's General Duty Clause requires employers to protect workers from recognized serious hazards — a framework that effectively reinforces state-level screening mandates.
How it works
Two primary screening methods are in active use, and understanding the difference between them matters for compliance purposes.
Tuberculin Skin Test (TST) — also called the Mantoux test or PPD test — involves injecting a small amount of purified protein derivative just under the skin of the forearm. A trained clinician reads the result 48 to 72 hours later, measuring induration (raised firmness, not just redness) in millimeters. A reading of 10 mm or greater is generally considered positive for healthcare and childcare workers, per CDC TB testing guidelines, though the threshold can shift based on individual risk factors.
Interferon-Gamma Release Assays (IGRAs) — sold under brand names including QuantiFERON-TB Gold Plus and T-SPOT.TB — are blood tests that measure the immune system's response to TB proteins. The CDC considers IGRAs preferred over TST for people who have received the BCG vaccine (common in many countries outside the U.S.), since BCG vaccination can cause false-positive TST results. A single blood draw replaces the two-visit TST process, which is a logistical advantage in high-turnover childcare environments.
A typical compliance pathway works like this:
The childcare health and hygiene standards at the state level typically specify which tests are acceptable, who may administer them, and what documentation format satisfies the licensing record requirement.
Common scenarios
Foreign-born workers with BCG history — This is one of the most common friction points. A worker born in a country where BCG vaccination is routine may test positive on TST despite having no TB infection. The appropriate response, per CDC guidance, is IGRA testing, not automatic exclusion. Facilities that default to TST-only protocols and treat BCG-vaccinated workers as positive without follow-up are misapplying the standard.
Workers with a prior positive result — Once a worker has a documented positive TST or IGRA, repeat skin testing is medically contraindicated and no longer informative. The worker instead undergoes symptom screening and, in some jurisdictions, periodic chest X-rays. Licensing inspectors sometimes flag the absence of a current TST result without recognizing the worker's documented prior positive history — a gap worth addressing in childcare facility inspection standards training.
Family childcare home providers — A single provider operating out of their own home is still subject to TB screening requirements in most states. The types of childcare settings matter here: an unlicensed, informal arrangement caring for fewer than the threshold number of children that triggers licensing may fall outside state TB screening mandates — but that does not mean the risk disappears.
Decision boundaries
The clearest line in TB screening policy is between screening and treatment decisions. Licensing agencies require documented screening. Treatment of LTBI — whether through isoniazid, rifapentine, or other regimens — is a clinical decision made by a licensed healthcare provider, not a licensing compliance matter. An employer cannot require a worker to complete LTBI treatment as a condition of employment without navigating significant legal complexity under the Americans with Disabilities Act, which the EEOC has addressed in the context of medical condition-based employment decisions.
A second decision boundary involves who counts as a "new employee" triggering pre-employment screening versus a transfer or rehire. States differ on whether documented prior screening within a defined window — commonly 12 months — satisfies the pre-employment requirement for a worker moving between licensed facilities. Checking the regulatory context for childcare in the relevant state is the only reliable way to resolve this.
The third boundary is the point at which active disease exclusion ends. No facility should make that determination independently. Re-entry requires written medical clearance confirming the worker has completed treatment and is no longer infectious — a standard anchored in CDC guidelines for TB in congregate settings and typically mirrored in state public health codes.